M
Myriad reports thick, high-grade uranium intervals at Copper Mountain, but results remain preliminary.
Myriad reports initial uranium concentration testing, but provides no quantitative results.
Myriad acquires Rush Rare Metals, but asset value and timeline remain unproven.
Myriad discloses only historical uranium estimates, not current resources or reserves.
Myriad finalizes Rush acquisition, issuing 25 million shares and spinning out Quebec assets.
Preliminary drill results show promise but lack assay confirmation and financial impact.
Big promises, but little current evidence—progress is mostly talk, not proven results.
This is a speculative land grab, not a proven uranium investment opportunity yet.
Early-stage uranium explorer touts potential, but real value is years and drill results away.
Myriad just turned a small uranium bet into real cash, not just promises.